Heart transplantation-An update

Everolimus in Heart Transplantation: An Update

The evidence base relating to the use of everolimus in heart transplantation has expanded considerably in recent years, providing clinically relevant information regarding its use in clinical practice. Unless there are special considerations to take into account, all de novo heart transplant patients can be regarded as potential candidates for immunosuppression with everolimus and reduced-expos...

Liver transplantation: an update.

Liver transplantation has been an accepted treatment for end-stage liver disease since the 1980s. Currently it is a highly successful treatment for this indication. The aim of this review is to give a general update on recent developments in the field of liver transplantation. In the last decades considerable progress has been made in the care of liver transplant candidates and recipients. At p...

Islet transplantation: an update.

Islet transplantation offers a physiological approach for precise restoration of glucose homeostasis, thereby reversing the metabolic and neurovascular complications of diabetes. In the past, there were only a few successes with human islet transplantation and the initial results were very disappointing. However, recent reports of great successes in islet transplantation have renewed the intere...

Small Intestinal Transplantation: An Update

Organ transplantation is indeed a revolution in management of end-stage organ failure. The one year graft survival rates for solid organs now routinely exceed 85 per cent for the kidney, liver and heart. The enhanced success rate is due to better immunosuppression, improvement in surgical techniques, organ preservation and better understanding of the immunology of rejection. The small intestine...

The pathology of heart and heart and lung transplantation--an update.